5 things to watch on the ASX 200 on Friday

The ASX 200 is expected to end the week on a positive note.

On Thursday, the S&P/ASX 200 Index (ASX: XJO) had a poor session and dropped into the red. The benchmark index fell 0.6% to 7,029.2 points.

Will the market be able to bounce back on Friday and end the week on a high? Here are five things to watch:

A young man sits at his desk working on his laptop with a big smile on his face.

Image source: Getty Images

ASX 200 expected to rise

The Australian share market looks set to end the week on a positive note. According to the latest SPI futures, the ASX 200 is expected to open 13 points or 0.2% higher this morning. Wall Street was closed for Thanksgiving, but European markets were higher. The DAX and the FTSE both rose 0.2%.

Oil prices fall

ASX 200 energy shares such as Beach Energy Ltd (ASX: BPT) and Woodside Energy Group Ltd (ASX: WDS) could end the week poorly after oil prices fell overnight. According to Bloomberg, the WTI crude oil price is down 0.95% to US$76.37 a barrel and the Brent crude oil price is down 0.8% to US$81.29 a barrel. Traders were selling oil after OPEC delayed its meeting.

AustralianSuper rejects Origin offer

Origin Energy Ltd (ASX: ORG) shares will be worth watching today after AustralianSuper rejected the revised takeover offer from Brookfied/EIG. The super fund said: "This latest low-ball offer strengthens AustralianSuper's view that the offer remains substantially below our estimate of Origin's long-term value."

Gold price edges higher

ASX 200 gold shares such as Evolution Mining Ltd (ASX: EVN) and Northern Star Resources Ltd (ASX: NST) will be on watch after the gold price edged higher overnight. According to CNBC, the spot gold price is up slightly to US$1,993.3 an ounce. A weaker US dollar boosted the precious metal.

Sell CBA shares

Commonwealth Bank of Australia (ASX: CBA) shares are overvalued according to analysts at Goldman Sachs. This morning, the broker has reiterated its sell rating on the banking giant's shares with an $81.64 price target. Goldman said: "CBA's consumer banking skew leaves its earnings more exposed to sector wide headwinds, including intense mortgage and deposit competition."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

Young successful engineer, with blueprints, notepad, and digital tablet, observing the project implementation on construction site and in mine.
Broker Notes

Why the Paladin Energy share price "doesn't make sense"

This uranium stock could be set for a major re-rating.

Read more »

Girl with painted hands.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a remarkably positive end to the trading week.

Read more »

Two miners standing together.
Broker Notes

3 ASX 200 mining shares to buy with 41% to 79% upside ahead: broker

The green energy transition and other factors are providing strong growth drivers for mining.

Read more »

Happy miner with his arms folded.
Broker Notes

Buy, hold, sell: Paladin Energy, Fortescue, Rio Tinto shares

Let's take a look at some new ratings from Morgans.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

9 ASX 200 shares experts are backing for growth amid market weakness

Brokers retained a positive view on BHP, CSL, Telstra, Xero, and other shares this week. 

Read more »

One large yellow sphere on one side of a white seesaw, with a small yellow sphere on the other side.
Opinions

I investigated 3 ASX shares that have fallen sharply. Are they bargains or value traps?

I've given my verdict on three depressed high-profile stocks.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

This ASX biotech could rise 40% or 750%, depending on who you ask

A poor quarter has reduced expectations, but there's still plenty of upside.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Opinions

These are the best 3 ASX growth shares I own and I'd buy more of today

I’m bullish about the earnings potential of these three ASX growth shares.

Read more »